Location: Home /  About MGI

MGI Statement

Release date:2021-02-20Writer:MGIViews:1226Share

In response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18 February 2021, MGI makes the following statement:


We welcome the Court’s decision to give us the permission to appeal the judgment, and we intend to file its appeal with the Court of Appeal. As permitted by the Court, we will continue to supply sequencing reagents to our existing customers in the UK during the appeal period.


Although MGI is appealing aspects of the judgement, it’s important to reiterate that we concur with the Court's previous ruling that Illumina’s European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is invalid for obviousness and that MGI’s CoolMPS sequencing method does NOT infringe this patent, as well as the finding that MGI’s CoolMPS sequencing does NOT infringe the EP 2 021 415 to a linker and rhodamine dye combination.


It should be noted that our advanced laboratory automation equipment is not affected by this lawsuit in any way. We will continue to do our utmost to protect the interests of our customers, research collaborators and business partners in the UK.


As a company that is committed to innovating core tools and technology to foster the global life-science industry development, we strongly oppose the abuse of patent litigation to maintain market monopoly and suppress fair competition.


  • Hotline (Global)
  • Email
  • Special Recommendations
  • *For research use only.

    Not for use in diagnostic procedures (except as specifically noted).
Our use of cookies
We would like to use necessary cookies to improve your browsing experience and the quality of our website. We would also like to set analytics cookies and advertisement cookies that help us make improvements by measuring how you use our website. Detailed information about the use of cookies on this website and how you can control your consent can be found in our Cookie Policy and Privacy Policy.
Accept only strictly necessary cookiesAccept all cookies